Lee KC - Search Results

1

PEGylated TNF-related apoptosis-inducing ligand (TRAIL) analogues: pharmacokinetics and antitumor effects.

Kim TH, Youn YS, Jiang HH, Lee S, Chen X, Lee KC. Kim TH, et al. Among authors: lee kc, lee s. Bioconjug Chem. 2011 Aug 17;22(8):1631-7. doi: 10.1021/bc200187k. Epub 2011 Jul 22. Bioconjug Chem. 2011. PMID: 21751817

2

Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer.

Kim I, Byeon HJ, Kim TH, Lee ES, Oh KT, Shin BS, Lee KC, Youn YS. Kim I, et al. Among authors: lee kc, lee es. Biomaterials. 2013 Sep;34(27):6444-53. doi: 10.1016/j.biomaterials.2013.05.018. Epub 2013 Jun 4. Biomaterials. 2013. PMID: 23755831

3

Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer.

Byeon HJ, Choi SH, Choi JS, Kim I, Shin BS, Lee ES, Park ES, Lee KC, Youn YS. Byeon HJ, et al. Among authors: lee kc, lee es. Acta Biomater. 2014 Jan;10(1):142-50. doi: 10.1016/j.actbio.2013.08.046. Epub 2013 Sep 8. Acta Biomater. 2014. PMID: 24021228

4

Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.

Byeon HJ, Choi SH, Choi JS, Kim TH, Lee ES, Lee KC, Youn YS. Byeon HJ, et al. Among authors: lee kc, lee es. Biomed Pharmacother. 2014 Feb;68(1):65-9. doi: 10.1016/j.biopha.2013.10.010. Epub 2013 Nov 7. Biomed Pharmacother. 2014. PMID: 24268811

5

Human serum albumin-TRAIL conjugate for the treatment of rheumatoid arthritis.

Byeon HJ, Min SY, Kim I, Lee ES, Oh KT, Shin BS, Lee KC, Youn YS. Byeon HJ, et al. Among authors: lee kc, lee es. Bioconjug Chem. 2014 Dec 17;25(12):2212-21. doi: 10.1021/bc500427g. Epub 2014 Nov 20. Bioconjug Chem. 2014. PMID: 25387356

6

Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1.

Lee SH, Lee S, Youn YS, Na DH, Chae SY, Byun Y, Lee KC. Lee SH, et al. Among authors: lee kc, lee s. Bioconjug Chem. 2005 Mar-Apr;16(2):377-82. doi: 10.1021/bc049735+. Bioconjug Chem. 2005. PMID: 15769092

7

Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).

Youn YS, Lee KC. Youn YS, et al. Among authors: lee kc. Bioconjug Chem. 2007 Mar-Apr;18(2):500-6. doi: 10.1021/bc060173z. Epub 2007 Jan 23. Bioconjug Chem. 2007. PMID: 17243755

8

Biological and physicochemical evaluation of the conformational stability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Youn YS, Shin MJ, Chae SY, Jin CH, Kim TH, Lee KC. Youn YS, et al. Among authors: lee kc. Biotechnol Lett. 2007 May;29(5):713-21. doi: 10.1007/s10529-006-9300-7. Epub 2007 Feb 23. Biotechnol Lett. 2007. PMID: 17318333

9

Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery.

Chae SY, Jin CH, Shin HJ, Youn YS, Lee S, Lee KC. Chae SY, et al. Among authors: lee kc, lee s. Bioconjug Chem. 2008 Jan;19(1):334-41. doi: 10.1021/bc700292v. Epub 2007 Dec 14. Bioconjug Chem. 2008. PMID: 18078308

10

Pharmacokinetic and pharmacodynamic evaluation of site-specific PEGylated glucagon-like peptide-1 analogs as flexible postprandial-glucose controllers.

Chae SY, Chun YG, Lee S, Jin CH, Lee ES, Lee KC, Youn YS. Chae SY, et al. Among authors: lee kc, lee es, lee s. J Pharm Sci. 2009 Apr;98(4):1556-67. doi: 10.1002/jps.21532. J Pharm Sci. 2009. PMID: 18704955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,319 results

Search Page

Filters